Krishnan Krish S

President and CEO, Director, 10% OwnerKrystal Biotech, Inc. (KRYS) · full profile →Form 4 · filed Jun 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7.7M
Net Open-Market Flow
-$7.7M
Transactions
11
11 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 4, 2026Sell(S)320$300.75$96K1.5M
Jun 4, 2026Sell(S)640$302.24$193K1.5M
Jun 4, 2026Sell(S)176$303.17$53K1.5M
Jun 4, 2026Sell(S)544$304.81$166K1.5M
Jun 4, 2026Sell(S)589$306.33$180K1.5M
Jun 4, 2026Sell(S)11K$307.68$3.5M1.5M
Jun 4, 2026Sell(S)5K$308.47$1.5M1.5M
Jun 4, 2026Sell(S)3K$309.49$862K1.5M
Jun 4, 2026Sell(S)3K$310.43$823K1.5M
Jun 4, 2026Sell(S)964$311.36$300K1.5M
Jun 4, 2026Sell(S)40$312.23$12K1.5M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001298709-26-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly: